Medical - Instruments & Supplies
Compare Stocks
5 / 10Stock Comparison
RVP vs DBVT vs ALKS vs NNBR vs PRGO
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
Biotechnology
Conglomerates
Drug Manufacturers - Specialty & Generic
RVP vs DBVT vs ALKS vs NNBR vs PRGO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Instruments & Supplies | Biotechnology | Biotechnology | Conglomerates | Drug Manufacturers - Specialty & Generic |
| Market Cap | $21M | $1712.35T | $5.90B | $139M | $1.61B |
| Revenue (TTM) | $38M | $0.00 | $1.56B | $435M | $4.18B |
| Net Income (TTM) | $-9M | $-168M | $153M | $-35M | $-1.82B |
| Gross Margin | -6.9% | — | 65.4% | 2.3% | 34.2% |
| Operating Margin | -58.1% | — | 12.3% | -3.3% | -4.1% |
| Forward P/E | — | — | 24.8x | 43.6x | 5.6x |
| Total Debt | $1M | $22M | $70M | $211M | $3.97B |
| Cash & Equiv. | $4M | $194M | $1.12B | $11M | $532M |
RVP vs DBVT vs ALKS vs NNBR vs PRGO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Retractable Technol… (RVP) | 100 | 13.0 | -87.0% |
| DBV Technologies S.… (DBVT) | 100 | 41.2 | -58.8% |
| Alkermes plc (ALKS) | 100 | 216.4 | +116.4% |
| NN, Inc. (NNBR) | 100 | 61.7 | -38.3% |
| Perrigo Company plc (PRGO) | 100 | 21.4 | -78.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RVP vs DBVT vs ALKS vs NNBR vs PRGO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RVP ranks third and is worth considering specifically for sleep-well-at-night and defensive.
- Lower volatility, beta 0.72, Low D/E 1.4%, current ratio 8.34x
- Beta 0.72, yield 1.1%, current ratio 8.34x
- Beta 0.72 vs NNBR's 2.04, lower leverage
DBVT is the clearest fit if your priority is momentum.
- +110.4% vs PRGO's -51.2%
ALKS is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth -5.2%, EPS growth -34.1%, 3Y rev CAGR 9.9%
- -11.0% 10Y total return vs NNBR's -75.7%
- 9.8% margin vs PRGO's -43.5%
- 5.4% ROA vs DBVT's -89.0%
Among these 5 stocks, NNBR doesn't own a clear edge in any measured category.
PRGO carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 10 yrs, beta 1.18, yield 9.8%
- -2.8% revenue growth vs DBVT's -100.0%
- Lower P/E (5.6x vs 43.6x)
- 9.8% yield, 10-year raise streak, vs RVP's 1.1%, (3 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -2.8% revenue growth vs DBVT's -100.0% | |
| Value | Lower P/E (5.6x vs 43.6x) | |
| Quality / Margins | 9.8% margin vs PRGO's -43.5% | |
| Stability / Safety | Beta 0.72 vs NNBR's 2.04, lower leverage | |
| Dividends | 9.8% yield, 10-year raise streak, vs RVP's 1.1%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +110.4% vs PRGO's -51.2% | |
| Efficiency (ROA) | 5.4% ROA vs DBVT's -89.0% |
RVP vs DBVT vs ALKS vs NNBR vs PRGO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
RVP vs DBVT vs ALKS vs NNBR vs PRGO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ALKS leads in 2 of 6 categories
PRGO leads 2 • NNBR leads 1 • RVP leads 0 • DBVT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ALKS leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PRGO and DBVT operate at a comparable scale, with $4.2B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, RVP holds the edge at +73.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $38M | $0 | $1.6B | $435M | $4.2B |
| EBITDAEarnings before interest/tax | -$15M | -$112M | $212M | $22M | $58M |
| Net IncomeAfter-tax profit | -$9M | -$168M | $153M | -$35M | -$1.8B |
| Free Cash FlowCash after capex | -$14M | -$151M | $392M | -$1M | $108M |
| Gross MarginGross profit ÷ Revenue | -6.9% | — | +65.4% | +2.3% | +34.2% |
| Operating MarginEBIT ÷ Revenue | -58.1% | — | +12.3% | -3.3% | -4.1% |
| Net MarginNet income ÷ Revenue | -22.9% | — | +9.8% | -8.0% | -43.5% |
| FCF MarginFCF ÷ Revenue | -35.5% | — | +25.1% | -0.3% | +2.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +73.2% | — | +28.2% | +12.1% | -7.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +99.0% | +91.5% | -4.1% | -8.7% | -56.4% |
Valuation Metrics
PRGO leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than NNBR's 19.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $21M | $1712.35T | $5.9B | $139M | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $18M | $1712.35T | $4.9B | $338M | $5.1B |
| Trailing P/EPrice ÷ TTM EPS | -1.76x | -0.76x | 24.76x | -2.58x | -1.14x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 43.60x | 5.56x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 17.25x | 19.03x | 7.42x |
| Price / SalesMarket cap ÷ Revenue | 0.64x | — | 4.00x | 0.33x | 0.38x |
| Price / BookPrice ÷ Book value/share | 0.24x | 0.66x | 3.28x | 0.93x | 0.55x |
| Price / FCFMarket cap ÷ FCF | — | — | 12.28x | 19.16x | 11.12x |
Profitability & Efficiency
ALKS leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
ALKS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-130 for DBVT. RVP carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to NNBR's 1.44x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs NNBR's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -11.4% | -130.2% | +8.8% | -28.4% | -50.7% |
| ROA (TTM)Return on assets | -5.9% | -89.0% | +5.4% | -7.7% | -19.8% |
| ROICReturn on invested capital | -18.4% | — | +18.9% | -4.5% | +3.7% |
| ROCEReturn on capital employed | -13.1% | -145.7% | +14.2% | -5.0% | +4.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 7 | 3 | 4 |
| Debt / EquityFinancial leverage | 0.01x | 0.13x | 0.04x | 1.44x | 1.35x |
| Net DebtTotal debt minus cash | -$3M | -$172M | -$1.0B | $200M | $3.4B |
| Cash & Equiv.Liquid assets | $4M | $194M | $1.1B | $11M | $532M |
| Total DebtShort + long-term debt | $1M | $22M | $70M | $211M | $4.0B |
| Interest CoverageEBIT ÷ Interest expense | -81.41x | -189.82x | 32.30x | -0.74x | -7.20x |
Total Returns (Dividends Reinvested)
NNBR leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $712 for RVP. Over the past 12 months, DBVT leads with a +110.4% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors NNBR at 40.7% vs PRGO's -25.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -7.2% | +4.9% | +25.3% | +106.0% | -13.5% |
| 1-Year ReturnPast 12 months | -6.3% | +110.4% | +16.5% | +50.8% | -51.2% |
| 3-Year ReturnCumulative with dividends | -55.4% | +19.7% | +14.5% | +178.4% | -58.1% |
| 5-Year ReturnCumulative with dividends | -92.9% | -69.1% | +60.9% | -63.4% | -60.1% |
| 10-Year ReturnCumulative with dividends | -69.9% | -87.0% | -11.0% | -75.7% | -77.7% |
| CAGR (3Y)Annualised 3-year return | -23.6% | +6.2% | +4.6% | +40.7% | -25.2% |
Risk & Volatility
Evenly matched — RVP and ALKS each lead in 1 of 2 comparable metrics.
Risk & Volatility
RVP is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than NNBR's 2.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.72x | 1.26x | 1.06x | 2.04x | 1.18x |
| 52-Week HighHighest price in past year | $1.14 | $26.18 | $36.60 | $2.99 | $28.44 |
| 52-Week LowLowest price in past year | $0.60 | $7.53 | $25.17 | $1.10 | $9.23 |
| % of 52W HighCurrent price vs 52-week peak | +61.8% | +76.3% | +96.7% | +92.3% | +41.2% |
| RSI (14)Momentum oscillator 0–100 | 55.3 | 48.1 | 60.2 | 65.6 | 60.9 |
| Avg Volume (50D)Average daily shares traded | 57K | 252K | 2.3M | 936K | 3.4M |
Analyst Outlook
PRGO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DBVT as "Buy", ALKS as "Buy", NNBR as "Buy", PRGO as "Hold". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 24.3% for ALKS (target: $44). For income investors, PRGO offers the higher dividend yield at 9.81% vs RVP's 1.09%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $46.33 | $44.00 | — | $20.00 |
| # AnalystsCovering analysts | — | 15 | 28 | 9 | 36 |
| Dividend YieldAnnual dividend ÷ price | +1.1% | — | — | — | +9.8% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 0 | 0 | 10 |
| Dividend / ShareAnnual DPS | $0.01 | — | — | — | $1.15 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.5% | 0.0% | 0.0% |
ALKS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
RVP vs DBVT vs ALKS vs NNBR vs PRGO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RVP or DBVT or ALKS or NNBR or PRGO a better buy right now?
For growth investors, Perrigo Company plc (PRGO) is the stronger pick with -2.
8% revenue growth year-over-year, versus -24. 2% for Retractable Technologies, Inc. (RVP). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RVP or DBVT or ALKS or NNBR or PRGO?
On forward P/E, Perrigo Company plc is actually cheaper at 5.
6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — RVP or DBVT or ALKS or NNBR or PRGO?
Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.
9%, compared to -92. 9% for Retractable Technologies, Inc. (RVP). Over 10 years, the gap is even starker: ALKS returned -11. 0% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RVP or DBVT or ALKS or NNBR or PRGO?
By beta (market sensitivity over 5 years), Retractable Technologies, Inc.
(RVP) is the lower-risk stock at 0. 72β versus NN, Inc. 's 2. 04β — meaning NNBR is approximately 185% more volatile than RVP relative to the S&P 500. On balance sheet safety, Retractable Technologies, Inc. (RVP) carries a lower debt/equity ratio of 1% versus 144% for NN, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — RVP or DBVT or ALKS or NNBR or PRGO?
By revenue growth (latest reported year), Perrigo Company plc (PRGO) is pulling ahead at -2.
8% versus -24. 2% for Retractable Technologies, Inc. (RVP). On earnings-per-share growth, the picture is similar: NN, Inc. grew EPS 3. 6% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RVP or DBVT or ALKS or NNBR or PRGO?
Alkermes plc (ALKS) is the more profitable company, earning 16.
4% net margin versus -36. 0% for Retractable Technologies, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -63. 9% for RVP. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RVP or DBVT or ALKS or NNBR or PRGO more undervalued right now?
On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.
6x forward P/E versus 43. 6x for NN, Inc. — 38. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.
08Which pays a better dividend — RVP or DBVT or ALKS or NNBR or PRGO?
In this comparison, PRGO (9.
8% yield), RVP (1. 1% yield) pay a dividend. DBVT, ALKS, NNBR do not pay a meaningful dividend and should not be held primarily for income.
09Is RVP or DBVT or ALKS or NNBR or PRGO better for a retirement portfolio?
For long-horizon retirement investors, Retractable Technologies, Inc.
(RVP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72), 1. 1% yield). NN, Inc. (NNBR) carries a higher beta of 2. 04 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (RVP: -69. 9%, NNBR: -75. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RVP and DBVT and ALKS and NNBR and PRGO?
These companies operate in different sectors (RVP (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and NNBR (Industrials) and PRGO (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RVP is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; NNBR is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock. RVP, PRGO pay a dividend while DBVT, ALKS, NNBR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.